Successful tocolysis: does cervical change affect time to delivery?
Generally, it is preferable to tocolyze patients with idiopathic preterm labor (PTL). Little information is available about ultimate outcomes after successful tocolysis. Our objective is to evaluate the relationship between cervical change after the initiation of tocolysis and the delay in time to delivery in patients with preterm labor. A historical analysis of all patients with successful tocolysis after PTL between January 1992 and December 1993 was undertaken. The patients were then placed in one of three categories (regression, unchanged, or progression) based on cervical change after the initiation of tocolysis. Various demographic pregnancy characteristics and pregnancy outcome data were analyzed. One hundred and twenty-six patients had successful tocolysis and met the admission criteria. Patients who had cervical progression had shorter delay to delivery, delivered at an earlier gestational age (31.7 weeks compared to 34.0 and 34.1 weeks, respectively, p < 0.05), and were more likely to deliver before 35 weeks (88% compared to 50.0 and 55.0%, respectively, p < 0.05). Also, neonates remained in the hospital longer and were more likely to have respiratory distress syndrome when compared to the other two groups. Patients who had cervical progression after the initiation of tocolysis are more likely to deliver prematurely, had a shorter delay to delivery, and delivered lower birth weight infants than did patients whose cervix regressed or remained unchanged. In our population, patients who had successful tocolysis had a preterm delivery rate of 59.5% before the 35th week of gestation.
Lewis
D F
DF
Louisiana State University Medical Center, Department of Obstetrics and Gynecology, Shreveport 71130-3932, USA.
Gallaspy
J W
JW
Fontenot
M T
MT
Burlison
R D
RD
Imseis
J M
JM
Edwards
M S
MS
D000293:Adolescent; D000328:Adult; D002584:Cervix Uteri / Q000000981:diagnostic imaging / Q000187:drug effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000517:prevention & control*; D011247:Pregnancy; D013726:Terbutaline / Q000627:therapeutic use*; D013997:Time Factors; D015149:Tocolytic Agents / Q000627:therapeutic use*; D016896:Treatment Outcome; D014463:Ultrasonography
D015149:Tocolytic Agents; D008278:Magnesium Sulfate; D013726:Terbutaline